We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Guidelines on MRI Safety and Compatibility of Medical Devices

By HospiMedica International staff writers
Posted on 13 Jan 2015
The US Food and Drug Administration issued new guidance recommendations on magnetic resonance imaging (MRI) compatibility—or in some instances, incompatibility—of implants that do not require electricity to service their function, such as intracranial aneurysm clips, cardiovascular stents, endovascular grafts, and transprostatic tissue retractors.

The topic of MRI-safe devices, up to now, has mostly centered on devices such as pacemakers, and more recently cochlear implants, both of which use electronics. More...
Now, however, the FDA (Silver Spring, MD, USA) has three principal concerns about patient safety in regards to these so-called “passive” implants in the MRI setting: the displacement forces and torques on magnetic substances, which can turn devices into deadly projectiles; radiofrequency heating that can burn patients; and the distorting effect of implants upon an MRI scan. The FDA recommends four tests described by standard setting institution, American Society for Testing and Materials (ASTM) International, to tackle these three safety issues, and provides additional details about the way those tests should be performed. For example, the guidance reported that “the testing should encompass the range of sizes of the device you intend to market.”

MRI scans are provided in various magnetic field strengths, measured in Teslas. “Although commercial 1.5 T MR systems are currently the most common, 3 T MR systems are becoming more common. A medical device that is classified as MR Conditional in a 1.5 T scanner may not be safe to scan in an MR system with a higher or lower field strength,” the guidance cautioned.

The implant’s labeling should describe the device as “MR Safe,” “MR Unsafe,” or “MR Conditional,” as defined by ASTM International in standard F2503-13. Lastly, the fourth category, “Safety in MRI Not Evaluated,” may be suitable in some instances, but not for those passive implants that are known to present MRI compatibility issues, are a new device type or contain ferromagnetic materials.

Related Links:

US Food and Drug Administration



New
Gold Member
Breast Imaging Monitor
Barco Coronis Onelook MDMC-32133 32MP
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Immobilization System
Cranial 4Pi Immobilization
Gas Analyzer
GE SAM
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Graphical Abstract (Aoibhin M. Sheedy et al., A replenishable peritoneal implant for localized delivery and peritoneal fluid sampling in ovarian cancer, Device (2026). DOI: 10.1016/j.device.2026.101050)

New Implant Provides Sustained Localized Therapy for Ovarian Cancer

Ovarian cancer is often diagnosed at advanced stages because symptoms such as bloating, pain, and pelvic pressure are nonspecific. Standard care relies on surgery and systemic therapy, yet tools for targeted... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.